Winton Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,915
Closed -$1.16M 603
2024
Q3
$1.16M Buy
23,915
+1,681
+8% +$73.8K 0.08% 213
2024
Q2
$889K Buy
22,234
+1,653
+8% +$68.5K 0.06% 340
2024
Q1
$904K Buy
20,581
+12,514
+155% +$646K 0.06% 322
2023
Q4
$499K Sell
8,067
-168
-2% -$8.82K 0.04% 316
2023
Q3
$379K Sell
8,235
-1,624
-16% -$88.6K 0.03% 430
2023
Q2
$567K Sell
9,859
-15,928
-62% -$706K 0.05% 272
2023
Q1
$967K Sell
25,787
-5,831
-18% -$191K 0.06% 459
2022
Q4
$886K Buy
31,618
+5,265
+20% +$153K 0.06% 450
2022
Q3
$741K Sell
26,353
-3,288
-11% -$107K 0.05% 516
2022
Q2
$1.03M Buy
29,641
+12,920
+77% +$461K 0.05% 478
2022
Q1
$600K Sell
16,721
-19,574
-54% -$555K 0.03% 629
2021
Q4
$845K Sell
36,295
-22,031
-38% -$450K 0.05% 516
2021
Q3
$1.11M Buy
58,326
+4,574
+9% +$89.6K 0.06% 450
2021
Q2
$1.08M Buy
53,752
+3,986
+8% +$75.1K 0.06% 487
2021
Q1
$912K Buy
49,766
+2,581
+5% +$48K 0.05% 524
2020
Q4
$949K Sell
47,185
-50,070
-51% -$974K 0.07% 431
2020
Q3
$1.82M Sell
97,255
-101,065
-51% -$2.03M 0.06% 570
2020
Q2
$4.45M Buy
198,320
+115,918
+141% +$2.12M 0.11% 266
2020
Q1
$1.22M Sell
82,402
-10,276
-11% -$179K 0.03% 720
2019
Q4
$1.79M Buy
92,678
+76,954
+489% +$1.48M 0.03% 837
2019
Q3
$312K Buy
+15,724
New +$328K ﹤0.01% 1265
2019
Q2
Sell
-11,781
Closed -$241K 1121
2019
Q1
$241K Buy
+11,781
New +$264K ﹤0.01% 893

Other funds holding AMPH